nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—type 2 diabetes mellitus	0.163	0.371	CbGaD
Pomalidomide—CYP1A2—type 2 diabetes mellitus	0.119	0.272	CbGaD
Pomalidomide—CYP3A4—type 2 diabetes mellitus	0.0791	0.18	CbGaD
Pomalidomide—PTGS2—type 2 diabetes mellitus	0.0774	0.176	CbGaD
Pomalidomide—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0335	0.104	CbGbCtD
Pomalidomide—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0299	0.0928	CbGbCtD
Pomalidomide—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0228	0.0708	CbGbCtD
Pomalidomide—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0216	0.0671	CbGbCtD
Pomalidomide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0201	0.0624	CbGbCtD
Pomalidomide—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0179	0.0557	CbGbCtD
Pomalidomide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0179	0.0556	CbGbCtD
Pomalidomide—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.017	0.0527	CbGbCtD
Pomalidomide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0164	0.0508	CbGbCtD
Pomalidomide—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0148	0.0461	CbGbCtD
Pomalidomide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0143	0.0444	CbGbCtD
Pomalidomide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0129	0.0402	CbGbCtD
Pomalidomide—CYP1A2—Losartan—type 2 diabetes mellitus	0.0116	0.0359	CbGbCtD
Pomalidomide—ABCB1—Glyburide—type 2 diabetes mellitus	0.0111	0.0343	CbGbCtD
Pomalidomide—ABCB1—Losartan—type 2 diabetes mellitus	0.0101	0.0314	CbGbCtD
Pomalidomide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0098	0.0305	CbGbCtD
Pomalidomide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0094	0.0292	CbGbCtD
Pomalidomide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0094	0.0292	CbGbCtD
Pomalidomide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00889	0.0276	CbGbCtD
Pomalidomide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00662	0.0206	CbGbCtD
Pomalidomide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00606	0.0188	CbGbCtD
Pomalidomide—Thalidomide—NFKB1—type 2 diabetes mellitus	0.00181	0.464	CrCbGaD
Pomalidomide—PTGS2—leg—type 2 diabetes mellitus	0.00138	0.0957	CbGeAlD
Pomalidomide—CRBN—islet of Langerhans—type 2 diabetes mellitus	0.00133	0.0924	CbGeAlD
Pomalidomide—PTGS2—hindlimb—type 2 diabetes mellitus	0.00123	0.0855	CbGeAlD
Pomalidomide—CRBN—retina—type 2 diabetes mellitus	0.00114	0.079	CbGeAlD
Pomalidomide—CRBN—nephron tubule—type 2 diabetes mellitus	0.00107	0.0744	CbGeAlD
Pomalidomide—CRBN—pancreas—type 2 diabetes mellitus	0.000938	0.065	CbGeAlD
Pomalidomide—CRBN—cortex of kidney—type 2 diabetes mellitus	0.00092	0.0637	CbGeAlD
Pomalidomide—CRBN—adipose tissue—type 2 diabetes mellitus	0.000851	0.059	CbGeAlD
Pomalidomide—PTGS2—artery—type 2 diabetes mellitus	0.000756	0.0524	CbGeAlD
Pomalidomide—PTGS2—endothelium—type 2 diabetes mellitus	0.000639	0.0443	CbGeAlD
Pomalidomide—CRBN—liver—type 2 diabetes mellitus	0.000597	0.0413	CbGeAlD
Pomalidomide—Thalidomide—TNF—type 2 diabetes mellitus	0.000555	0.142	CrCbGaD
Pomalidomide—Lenalidomide—PTGS2—type 2 diabetes mellitus	0.00044	0.113	CrCbGaD
Pomalidomide—Thalidomide—CYP2E1—type 2 diabetes mellitus	0.000427	0.11	CrCbGaD
Pomalidomide—Thalidomide—CYP1A2—type 2 diabetes mellitus	0.000407	0.104	CrCbGaD
Pomalidomide—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000363	0.0252	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—type 2 diabetes mellitus	0.000264	0.0675	CrCbGaD
Pomalidomide—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000263	0.0182	CbGeAlD
Pomalidomide—PTGS2—kidney—type 2 diabetes mellitus	0.000257	0.0178	CbGeAlD
Pomalidomide—PTGS2—pancreas—type 2 diabetes mellitus	0.000255	0.0177	CbGeAlD
Pomalidomide—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000232	0.0161	CbGeAlD
Pomalidomide—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000225	0.0156	CbGeAlD
Pomalidomide—CYP3A4—kidney—type 2 diabetes mellitus	0.000225	0.0156	CbGeAlD
Pomalidomide—CYP1A2—liver—type 2 diabetes mellitus	0.000196	0.0136	CbGeAlD
Pomalidomide—ABCB1—retina—type 2 diabetes mellitus	0.000192	0.0133	CbGeAlD
Pomalidomide—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000181	0.0125	CbGeAlD
Pomalidomide—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000163	0.0113	CbGeAlD
Pomalidomide—PTGS2—liver—type 2 diabetes mellitus	0.000163	0.0113	CbGeAlD
Pomalidomide—ABCB1—kidney—type 2 diabetes mellitus	0.000159	0.011	CbGeAlD
Pomalidomide—ABCB1—pancreas—type 2 diabetes mellitus	0.000158	0.0109	CbGeAlD
Pomalidomide—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000155	0.0107	CbGeAlD
Pomalidomide—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000143	0.00993	CbGeAlD
Pomalidomide—CYP3A4—liver—type 2 diabetes mellitus	0.000142	0.00984	CbGeAlD
Pomalidomide—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000132	0.000961	CcSEcCtD
Pomalidomide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000132	0.000961	CcSEcCtD
Pomalidomide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000131	0.000954	CcSEcCtD
Pomalidomide—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000131	0.000953	CcSEcCtD
Pomalidomide—Cough—Orlistat—type 2 diabetes mellitus	0.000131	0.000953	CcSEcCtD
Pomalidomide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00013	0.000951	CcSEcCtD
Pomalidomide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00013	0.00095	CcSEcCtD
Pomalidomide—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.00013	0.00095	CcSEcCtD
Pomalidomide—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00013	0.000949	CcSEcCtD
Pomalidomide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00013	0.000948	CcSEcCtD
Pomalidomide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00013	0.000946	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000129	0.000944	CcSEcCtD
Pomalidomide—Tremor—Metformin—type 2 diabetes mellitus	0.000129	0.000943	CcSEcCtD
Pomalidomide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000129	0.000941	CcSEcCtD
Pomalidomide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000129	0.000939	CcSEcCtD
Pomalidomide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000129	0.000938	CcSEcCtD
Pomalidomide—Anxiety—Valsartan—type 2 diabetes mellitus	0.000129	0.000938	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000128	0.000934	CcSEcCtD
Pomalidomide—Angiopathy—Losartan—type 2 diabetes mellitus	0.000128	0.000932	CcSEcCtD
Pomalidomide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000128	0.000931	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000127	0.000928	CcSEcCtD
Pomalidomide—Anxiety—Orlistat—type 2 diabetes mellitus	0.000127	0.000927	CcSEcCtD
Pomalidomide—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000127	0.000925	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000127	0.000923	CcSEcCtD
Pomalidomide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000125	0.000913	CcSEcCtD
Pomalidomide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000124	0.000907	CcSEcCtD
Pomalidomide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000124	0.000904	CcSEcCtD
Pomalidomide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000124	0.000903	CcSEcCtD
Pomalidomide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000124	0.000901	CcSEcCtD
Pomalidomide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000123	0.0009	CcSEcCtD
Pomalidomide—Infection—Valsartan—type 2 diabetes mellitus	0.000123	0.000896	CcSEcCtD
Pomalidomide—Rash—Glipizide—type 2 diabetes mellitus	0.000123	0.000896	CcSEcCtD
Pomalidomide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000123	0.000895	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000123	0.000895	CcSEcCtD
Pomalidomide—Headache—Glipizide—type 2 diabetes mellitus	0.000122	0.00089	CcSEcCtD
Pomalidomide—Tremor—Irbesartan—type 2 diabetes mellitus	0.000122	0.00089	CcSEcCtD
Pomalidomide—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000122	0.000888	CcSEcCtD
Pomalidomide—Infection—Orlistat—type 2 diabetes mellitus	0.000121	0.000886	CcSEcCtD
Pomalidomide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000121	0.000885	CcSEcCtD
Pomalidomide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000121	0.000883	CcSEcCtD
Pomalidomide—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000878	CcSEcCtD
Pomalidomide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00012	0.000877	CcSEcCtD
Pomalidomide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00012	0.000876	CcSEcCtD
Pomalidomide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00012	0.000875	CcSEcCtD
Pomalidomide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00012	0.000874	CcSEcCtD
Pomalidomide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00012	0.000874	CcSEcCtD
Pomalidomide—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000119	0.000867	CcSEcCtD
Pomalidomide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000119	0.000866	CcSEcCtD
Pomalidomide—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000119	0.000865	CcSEcCtD
Pomalidomide—Back pain—Losartan—type 2 diabetes mellitus	0.000119	0.000865	CcSEcCtD
Pomalidomide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000118	0.000862	CcSEcCtD
Pomalidomide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000118	0.000859	CcSEcCtD
Pomalidomide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000858	CcSEcCtD
Pomalidomide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000117	0.000853	CcSEcCtD
Pomalidomide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000117	0.000853	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000117	0.000851	CcSEcCtD
Pomalidomide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000117	0.00085	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000116	0.000848	CcSEcCtD
Pomalidomide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000116	0.000846	CcSEcCtD
Pomalidomide—Nausea—Glipizide—type 2 diabetes mellitus	0.000116	0.000844	CcSEcCtD
Pomalidomide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000116	0.000843	CcSEcCtD
Pomalidomide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000115	0.00084	CcSEcCtD
Pomalidomide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000115	0.00084	CcSEcCtD
Pomalidomide—Pain—Gliclazide—type 2 diabetes mellitus	0.000115	0.00084	CcSEcCtD
Pomalidomide—Tremor—Losartan—type 2 diabetes mellitus	0.000115	0.000837	CcSEcCtD
Pomalidomide—Rash—Glimepiride—type 2 diabetes mellitus	0.000115	0.000836	CcSEcCtD
Pomalidomide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000115	0.000835	CcSEcCtD
Pomalidomide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000833	CcSEcCtD
Pomalidomide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000833	CcSEcCtD
Pomalidomide—Headache—Glimepiride—type 2 diabetes mellitus	0.000114	0.000831	CcSEcCtD
Pomalidomide—Cough—Irbesartan—type 2 diabetes mellitus	0.000114	0.000829	CcSEcCtD
Pomalidomide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000828	CcSEcCtD
Pomalidomide—Anaemia—Losartan—type 2 diabetes mellitus	0.000113	0.000826	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000113	0.000822	CcSEcCtD
Pomalidomide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000818	CcSEcCtD
Pomalidomide—Infection—Metformin—type 2 diabetes mellitus	0.000112	0.000816	CcSEcCtD
Pomalidomide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000112	0.000816	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000111	0.000812	CcSEcCtD
Pomalidomide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000111	0.000809	CcSEcCtD
Pomalidomide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000809	CcSEcCtD
Pomalidomide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000111	0.000806	CcSEcCtD
Pomalidomide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000111	0.000806	CcSEcCtD
Pomalidomide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00011	0.000806	CcSEcCtD
Pomalidomide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00011	0.000806	CcSEcCtD
Pomalidomide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00011	0.000804	CcSEcCtD
Pomalidomide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00011	0.000804	CcSEcCtD
Pomalidomide—Vertigo—Losartan—type 2 diabetes mellitus	0.00011	0.000803	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00011	0.000803	CcSEcCtD
Pomalidomide—Leukopenia—Losartan—type 2 diabetes mellitus	0.00011	0.0008	CcSEcCtD
Pomalidomide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000109	0.000798	CcSEcCtD
Pomalidomide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000109	0.000794	CcSEcCtD
Pomalidomide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000794	CcSEcCtD
Pomalidomide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000108	0.000791	CcSEcCtD
Pomalidomide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000108	0.000788	CcSEcCtD
Pomalidomide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000108	0.000785	CcSEcCtD
Pomalidomide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000108	0.000784	CcSEcCtD
Pomalidomide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000108	0.000784	CcSEcCtD
Pomalidomide—Cough—Losartan—type 2 diabetes mellitus	0.000107	0.00078	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000107	0.000779	CcSEcCtD
Pomalidomide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000107	0.000778	CcSEcCtD
Pomalidomide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000106	0.000776	CcSEcCtD
Pomalidomide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000106	0.000775	CcSEcCtD
Pomalidomide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000106	0.000774	CcSEcCtD
Pomalidomide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000106	0.000771	CcSEcCtD
Pomalidomide—Constipation—Valsartan—type 2 diabetes mellitus	0.000106	0.000771	CcSEcCtD
Pomalidomide—Infection—Irbesartan—type 2 diabetes mellitus	0.000106	0.00077	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000106	0.00077	CcSEcCtD
Pomalidomide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000105	0.000768	CcSEcCtD
Pomalidomide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000105	0.000766	CcSEcCtD
Pomalidomide—Pain—Orlistat—type 2 diabetes mellitus	0.000105	0.000762	CcSEcCtD
Pomalidomide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000104	0.000761	CcSEcCtD
Pomalidomide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00076	CcSEcCtD
Pomalidomide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.00076	CcSEcCtD
Pomalidomide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000759	CcSEcCtD
Pomalidomide—Anxiety—Losartan—type 2 diabetes mellitus	0.000104	0.000758	CcSEcCtD
Pomalidomide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000754	CcSEcCtD
Pomalidomide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000753	CcSEcCtD
Pomalidomide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000103	0.000753	CcSEcCtD
Pomalidomide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000103	0.000749	CcSEcCtD
Pomalidomide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000749	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000103	0.000748	CcSEcCtD
Pomalidomide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000103	0.000748	CcSEcCtD
Pomalidomide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000101	0.000737	CcSEcCtD
Pomalidomide—Confusional state—Losartan—type 2 diabetes mellitus	0.000101	0.000736	CcSEcCtD
Pomalidomide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000101	0.000735	CcSEcCtD
Pomalidomide—ABCB1—liver—type 2 diabetes mellitus	0.000101	0.00696	CbGeAlD
Pomalidomide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.0001	0.000732	CcSEcCtD
Pomalidomide—Infection—Losartan—type 2 diabetes mellitus	9.94e-05	0.000725	CcSEcCtD
Pomalidomide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.92e-05	0.000723	CcSEcCtD
Pomalidomide—Tremor—Ramipril—type 2 diabetes mellitus	9.85e-05	0.000718	CcSEcCtD
Pomalidomide—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.81e-05	0.000715	CcSEcCtD
Pomalidomide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.79e-05	0.000714	CcSEcCtD
Pomalidomide—Decreased appetite—Metformin—type 2 diabetes mellitus	9.79e-05	0.000714	CcSEcCtD
Pomalidomide—Nausea—Bromocriptine—type 2 diabetes mellitus	9.74e-05	0.00071	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.72e-05	0.000709	CcSEcCtD
Pomalidomide—Fatigue—Metformin—type 2 diabetes mellitus	9.71e-05	0.000708	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.000706	CcSEcCtD
Pomalidomide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.67e-05	0.000705	CcSEcCtD
Pomalidomide—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.66e-05	0.000705	CcSEcCtD
Pomalidomide—Asthenia—Gliclazide—type 2 diabetes mellitus	9.66e-05	0.000704	CcSEcCtD
Pomalidomide—Constipation—Metformin—type 2 diabetes mellitus	9.63e-05	0.000702	CcSEcCtD
Pomalidomide—Vomiting—Glyburide—type 2 diabetes mellitus	9.53e-05	0.000695	CcSEcCtD
Pomalidomide—Pruritus—Gliclazide—type 2 diabetes mellitus	9.52e-05	0.000695	CcSEcCtD
Pomalidomide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.48e-05	0.000691	CcSEcCtD
Pomalidomide—Rash—Glyburide—type 2 diabetes mellitus	9.45e-05	0.000689	CcSEcCtD
Pomalidomide—Dermatitis—Glyburide—type 2 diabetes mellitus	9.44e-05	0.000689	CcSEcCtD
Pomalidomide—Vertigo—Ramipril—type 2 diabetes mellitus	9.44e-05	0.000689	CcSEcCtD
Pomalidomide—Leukopenia—Ramipril—type 2 diabetes mellitus	9.41e-05	0.000686	CcSEcCtD
Pomalidomide—Headache—Glyburide—type 2 diabetes mellitus	9.39e-05	0.000685	CcSEcCtD
Pomalidomide—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.28e-05	0.000677	CcSEcCtD
Pomalidomide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.24e-05	0.000674	CcSEcCtD
Pomalidomide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.21e-05	0.000672	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.18e-05	0.000669	CcSEcCtD
Pomalidomide—Cough—Ramipril—type 2 diabetes mellitus	9.17e-05	0.000669	CcSEcCtD
Pomalidomide—Fatigue—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000668	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.11e-05	0.000665	CcSEcCtD
Pomalidomide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.11e-05	0.000665	CcSEcCtD
Pomalidomide—Constipation—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000663	CcSEcCtD
Pomalidomide—Pain—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000663	CcSEcCtD
Pomalidomide—Insomnia—Losartan—type 2 diabetes mellitus	9.05e-05	0.00066	CcSEcCtD
Pomalidomide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9e-05	0.000657	CcSEcCtD
Pomalidomide—Arthralgia—Ramipril—type 2 diabetes mellitus	8.95e-05	0.000653	CcSEcCtD
Pomalidomide—Dyspnoea—Losartan—type 2 diabetes mellitus	8.92e-05	0.00065	CcSEcCtD
Pomalidomide—Anxiety—Ramipril—type 2 diabetes mellitus	8.92e-05	0.00065	CcSEcCtD
Pomalidomide—Nausea—Glyburide—type 2 diabetes mellitus	8.91e-05	0.000649	CcSEcCtD
Pomalidomide—Dizziness—Gliclazide—type 2 diabetes mellitus	8.9e-05	0.000649	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000648	CcSEcCtD
Pomalidomide—Asthenia—Valsartan—type 2 diabetes mellitus	8.87e-05	0.000647	CcSEcCtD
Pomalidomide—Asthenia—Orlistat—type 2 diabetes mellitus	8.77e-05	0.00064	CcSEcCtD
Pomalidomide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.76e-05	0.000639	CcSEcCtD
Pomalidomide—Pruritus—Valsartan—type 2 diabetes mellitus	8.75e-05	0.000638	CcSEcCtD
Pomalidomide—Decreased appetite—Losartan—type 2 diabetes mellitus	8.7e-05	0.000634	CcSEcCtD
Pomalidomide—Confusional state—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000631	CcSEcCtD
Pomalidomide—Pruritus—Orlistat—type 2 diabetes mellitus	8.65e-05	0.000631	CcSEcCtD
Pomalidomide—Fatigue—Losartan—type 2 diabetes mellitus	8.62e-05	0.000629	CcSEcCtD
Pomalidomide—Vomiting—Gliclazide—type 2 diabetes mellitus	8.56e-05	0.000624	CcSEcCtD
Pomalidomide—Pain—Losartan—type 2 diabetes mellitus	8.55e-05	0.000624	CcSEcCtD
Pomalidomide—Constipation—Losartan—type 2 diabetes mellitus	8.55e-05	0.000624	CcSEcCtD
Pomalidomide—Rash—Gliclazide—type 2 diabetes mellitus	8.49e-05	0.000619	CcSEcCtD
Pomalidomide—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.48e-05	0.000618	CcSEcCtD
Pomalidomide—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.46e-05	0.000617	CcSEcCtD
Pomalidomide—Headache—Gliclazide—type 2 diabetes mellitus	8.43e-05	0.000615	CcSEcCtD
Pomalidomide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.41e-05	0.000613	CcSEcCtD
Pomalidomide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000613	CcSEcCtD
Pomalidomide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000612	CcSEcCtD
Pomalidomide—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.36e-05	0.00061	CcSEcCtD
Pomalidomide—Skin disorder—Ramipril—type 2 diabetes mellitus	8.33e-05	0.000608	CcSEcCtD
Pomalidomide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.29e-05	0.000605	CcSEcCtD
Pomalidomide—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.24e-05	0.000601	CcSEcCtD
Pomalidomide—Dizziness—Valsartan—type 2 diabetes mellitus	8.18e-05	0.000596	CcSEcCtD
Pomalidomide—Dizziness—Orlistat—type 2 diabetes mellitus	8.08e-05	0.000589	CcSEcCtD
Pomalidomide—Asthenia—Metformin—type 2 diabetes mellitus	8.08e-05	0.000589	CcSEcCtD
Pomalidomide—Nausea—Gliclazide—type 2 diabetes mellitus	8e-05	0.000583	CcSEcCtD
Pomalidomide—Pruritus—Metformin—type 2 diabetes mellitus	7.97e-05	0.000581	CcSEcCtD
Pomalidomide—Body temperature increased—Losartan—type 2 diabetes mellitus	7.91e-05	0.000577	CcSEcCtD
Pomalidomide—Vomiting—Valsartan—type 2 diabetes mellitus	7.86e-05	0.000574	CcSEcCtD
Pomalidomide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000571	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.81e-05	0.00057	CcSEcCtD
Pomalidomide—Rash—Valsartan—type 2 diabetes mellitus	7.8e-05	0.000569	CcSEcCtD
Pomalidomide—Dermatitis—Valsartan—type 2 diabetes mellitus	7.79e-05	0.000568	CcSEcCtD
Pomalidomide—Vomiting—Orlistat—type 2 diabetes mellitus	7.77e-05	0.000567	CcSEcCtD
Pomalidomide—Insomnia—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000566	CcSEcCtD
Pomalidomide—Headache—Valsartan—type 2 diabetes mellitus	7.75e-05	0.000565	CcSEcCtD
Pomalidomide—Diarrhoea—Metformin—type 2 diabetes mellitus	7.71e-05	0.000562	CcSEcCtD
Pomalidomide—Rash—Orlistat—type 2 diabetes mellitus	7.71e-05	0.000562	CcSEcCtD
Pomalidomide—Dermatitis—Orlistat—type 2 diabetes mellitus	7.7e-05	0.000561	CcSEcCtD
Pomalidomide—Headache—Orlistat—type 2 diabetes mellitus	7.66e-05	0.000558	CcSEcCtD
Pomalidomide—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000558	CcSEcCtD
Pomalidomide—Asthenia—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.000556	CcSEcCtD
Pomalidomide—Pruritus—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000548	CcSEcCtD
Pomalidomide—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.46e-05	0.000544	CcSEcCtD
Pomalidomide—Dizziness—Metformin—type 2 diabetes mellitus	7.45e-05	0.000543	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.41e-05	0.00054	CcSEcCtD
Pomalidomide—Fatigue—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000539	CcSEcCtD
Pomalidomide—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.37e-05	0.000537	CcSEcCtD
Pomalidomide—Nausea—Valsartan—type 2 diabetes mellitus	7.35e-05	0.000536	CcSEcCtD
Pomalidomide—Constipation—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000535	CcSEcCtD
Pomalidomide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.27e-05	0.00053	CcSEcCtD
Pomalidomide—Nausea—Orlistat—type 2 diabetes mellitus	7.26e-05	0.000529	CcSEcCtD
Pomalidomide—Asthenia—Losartan—type 2 diabetes mellitus	7.18e-05	0.000523	CcSEcCtD
Pomalidomide—Vomiting—Metformin—type 2 diabetes mellitus	7.16e-05	0.000522	CcSEcCtD
Pomalidomide—Rash—Metformin—type 2 diabetes mellitus	7.1e-05	0.000518	CcSEcCtD
Pomalidomide—Dermatitis—Metformin—type 2 diabetes mellitus	7.1e-05	0.000517	CcSEcCtD
Pomalidomide—Pruritus—Losartan—type 2 diabetes mellitus	7.08e-05	0.000516	CcSEcCtD
Pomalidomide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000515	CcSEcCtD
Pomalidomide—Headache—Metformin—type 2 diabetes mellitus	7.06e-05	0.000515	CcSEcCtD
Pomalidomide—Dizziness—Irbesartan—type 2 diabetes mellitus	7.03e-05	0.000513	CcSEcCtD
Pomalidomide—Diarrhoea—Losartan—type 2 diabetes mellitus	6.84e-05	0.000499	CcSEcCtD
Pomalidomide—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000495	CcSEcCtD
Pomalidomide—Vomiting—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000493	CcSEcCtD
Pomalidomide—Rash—Irbesartan—type 2 diabetes mellitus	6.7e-05	0.000489	CcSEcCtD
Pomalidomide—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.7e-05	0.000488	CcSEcCtD
Pomalidomide—Nausea—Metformin—type 2 diabetes mellitus	6.69e-05	0.000488	CcSEcCtD
Pomalidomide—Headache—Irbesartan—type 2 diabetes mellitus	6.66e-05	0.000486	CcSEcCtD
Pomalidomide—Dizziness—Losartan—type 2 diabetes mellitus	6.62e-05	0.000482	CcSEcCtD
Pomalidomide—Vomiting—Losartan—type 2 diabetes mellitus	6.36e-05	0.000464	CcSEcCtD
Pomalidomide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000461	CcSEcCtD
Pomalidomide—Nausea—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.00046	CcSEcCtD
Pomalidomide—Rash—Losartan—type 2 diabetes mellitus	6.31e-05	0.00046	CcSEcCtD
Pomalidomide—Dermatitis—Losartan—type 2 diabetes mellitus	6.3e-05	0.00046	CcSEcCtD
Pomalidomide—Headache—Losartan—type 2 diabetes mellitus	6.27e-05	0.000457	CcSEcCtD
Pomalidomide—Asthenia—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000449	CcSEcCtD
Pomalidomide—Pruritus—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000443	CcSEcCtD
Pomalidomide—Nausea—Losartan—type 2 diabetes mellitus	5.94e-05	0.000433	CcSEcCtD
Pomalidomide—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000428	CcSEcCtD
Pomalidomide—Dizziness—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000414	CcSEcCtD
Pomalidomide—Vomiting—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000398	CcSEcCtD
Pomalidomide—Rash—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000394	CcSEcCtD
Pomalidomide—Dermatitis—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000394	CcSEcCtD
Pomalidomide—Headache—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000392	CcSEcCtD
Pomalidomide—Nausea—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000372	CcSEcCtD
Pomalidomide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.38e-06	8.81e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.38e-06	8.81e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.38e-06	8.81e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.38e-06	8.81e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.38e-06	8.81e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	7.37e-06	8.8e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.36e-06	8.79e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	7.24e-06	8.65e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	7.24e-06	8.65e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	7.24e-06	8.65e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.14e-06	8.53e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.09e-06	8.47e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.05e-06	8.42e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.02e-06	8.38e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.01e-06	8.37e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	7.01e-06	8.37e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	6.99e-06	8.34e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	6.88e-06	8.21e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.84e-06	8.17e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	6.81e-06	8.13e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	6.77e-06	8.08e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.75e-06	8.05e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.75e-06	8.05e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	6.72e-06	8.03e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.72e-06	8.03e-05	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—type 2 diabetes mellitus	6.71e-06	8.01e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.71e-06	8e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.62e-06	7.9e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOB—type 2 diabetes mellitus	6.6e-06	7.88e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.58e-06	7.85e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.54e-06	7.81e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.42e-06	7.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	6.38e-06	7.61e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.37e-06	7.61e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LPL—type 2 diabetes mellitus	6.3e-06	7.52e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	6.29e-06	7.51e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	6.29e-06	7.51e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.27e-06	7.49e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.27e-06	7.49e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.27e-06	7.49e-05	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—type 2 diabetes mellitus	6.19e-06	7.39e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	6.17e-06	7.36e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	6.17e-06	7.36e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	6.16e-06	7.35e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	6.16e-06	7.35e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	6.16e-06	7.35e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	6.16e-06	7.35e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	6.13e-06	7.32e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	6.13e-06	7.32e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	6.13e-06	7.32e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.09e-06	7.27e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.01e-06	7.18e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.01e-06	7.18e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.98e-06	7.14e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.92e-06	7.07e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.91e-06	7.06e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	5.91e-06	7.06e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	5.91e-06	7.05e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.81e-06	6.93e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CCR5—type 2 diabetes mellitus	5.81e-06	6.93e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	5.8e-06	6.92e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.8e-06	6.92e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.79e-06	6.91e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.79e-06	6.91e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	5.77e-06	6.89e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.74e-06	6.85e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	5.69e-06	6.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.69e-06	6.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	5.67e-06	6.77e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.62e-06	6.71e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.59e-06	6.67e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.59e-06	6.67e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.59e-06	6.67e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.56e-06	6.63e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	5.53e-06	6.6e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.5e-06	6.56e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.5e-06	6.56e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.5e-06	6.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.49e-06	6.55e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	5.41e-06	6.46e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IRS2—type 2 diabetes mellitus	5.4e-06	6.44e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.4e-06	6.44e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	5.38e-06	6.42e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.35e-06	6.38e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CALM1—type 2 diabetes mellitus	5.3e-06	6.33e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—type 2 diabetes mellitus	5.28e-06	6.31e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	5.28e-06	6.3e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.26e-06	6.28e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.24e-06	6.26e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.23e-06	6.25e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOA1—type 2 diabetes mellitus	5.22e-06	6.23e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	5.17e-06	6.17e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	5.15e-06	6.15e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.13e-06	6.12e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.03e-06	6e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.02e-06	5.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.02e-06	5.99e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	5.01e-06	5.99e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.97e-06	5.94e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.97e-06	5.94e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.95e-06	5.91e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.92e-06	5.88e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.92e-06	5.88e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—type 2 diabetes mellitus	4.92e-06	5.88e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.9e-06	5.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.89e-06	5.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.89e-06	5.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.89e-06	5.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.86e-06	5.81e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.85e-06	5.79e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.78e-06	5.7e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.77e-06	5.69e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.77e-06	5.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.75e-06	5.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.75e-06	5.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.75e-06	5.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.75e-06	5.68e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	4.75e-06	5.67e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.72e-06	5.64e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IRS1—type 2 diabetes mellitus	4.71e-06	5.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	4.66e-06	5.56e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.56e-06	5.44e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	4.51e-06	5.39e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—type 2 diabetes mellitus	4.51e-06	5.39e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	4.44e-06	5.3e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	4.42e-06	5.28e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.4e-06	5.26e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.39e-06	5.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.39e-06	5.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.39e-06	5.24e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	4.37e-06	5.22e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT2—type 2 diabetes mellitus	4.36e-06	5.21e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.31e-06	5.14e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.27e-06	5.1e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.24e-06	5.06e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.21e-06	5.03e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.18e-06	4.99e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	4.14e-06	4.95e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.11e-06	4.9e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.11e-06	4.9e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.09e-06	4.88e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.04e-06	4.82e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.01e-06	4.79e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.97e-06	4.74e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—type 2 diabetes mellitus	3.96e-06	4.72e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	3.96e-06	4.72e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.96e-06	4.72e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.92e-06	4.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.88e-06	4.63e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.88e-06	4.63e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.87e-06	4.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	3.85e-06	4.6e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.85e-06	4.6e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.81e-06	4.55e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.81e-06	4.54e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.81e-06	4.54e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.8e-06	4.54e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—type 2 diabetes mellitus	3.78e-06	4.51e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.78e-06	4.51e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.78e-06	4.51e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.78e-06	4.51e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.75e-06	4.48e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.74e-06	4.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.69e-06	4.4e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.66e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.65e-06	4.36e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.64e-06	4.35e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.55e-06	4.24e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.51e-06	4.19e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	3.46e-06	4.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.39e-06	4.04e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.39e-06	4.04e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.39e-06	4.04e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.37e-06	4.02e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.32e-06	3.97e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.31e-06	3.96e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	3.31e-06	3.96e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.3e-06	3.94e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.3e-06	3.93e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.28e-06	3.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.28e-06	3.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.27e-06	3.9e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.22e-06	3.85e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.22e-06	3.85e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.2e-06	3.82e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.15e-06	3.76e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.14e-06	3.74e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.13e-06	3.73e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.1e-06	3.7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.1e-06	3.7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.06e-06	3.66e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.06e-06	3.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.04e-06	3.63e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.99e-06	3.56e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.94e-06	3.51e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.94e-06	3.51e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SRC—type 2 diabetes mellitus	2.93e-06	3.49e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.92e-06	3.49e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.91e-06	3.48e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.84e-06	3.39e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.8e-06	3.34e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.73e-06	3.26e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.69e-06	3.21e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.68e-06	3.2e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.64e-06	3.15e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	2.62e-06	3.12e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGFR—type 2 diabetes mellitus	2.57e-06	3.06e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.55e-06	3.05e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.53e-06	3.02e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.53e-06	3.02e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.52e-06	3.01e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.51e-06	3e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.5e-06	2.99e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.49e-06	2.97e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.47e-06	2.95e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.46e-06	2.93e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.41e-06	2.88e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.35e-06	2.8e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.35e-06	2.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.35e-06	2.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.3e-06	2.75e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.26e-06	2.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.25e-06	2.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.19e-06	2.61e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.18e-06	2.6e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.16e-06	2.58e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.15e-06	2.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.14e-06	2.55e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.08e-06	2.48e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.04e-06	2.43e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.97e-06	2.35e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—type 2 diabetes mellitus	1.97e-06	2.35e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.96e-06	2.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.94e-06	2.31e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.93e-06	2.31e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.91e-06	2.28e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.88e-06	2.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.88e-06	2.24e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—type 2 diabetes mellitus	1.82e-06	2.17e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.72e-06	2.05e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.68e-06	2.01e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.65e-06	1.97e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.52e-06	1.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.51e-06	1.81e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-06	1.73e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.73e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	1.58e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.29e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.62e-07	1.03e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.65e-07	7.94e-06	CbGpPWpGaD
